Abiomed
(NASDAQ) ABMD
Abiomed Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$1.07B
Net Income (TTM)
$266.76M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ABMD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Abiomed
Industry
{'id': 40, 'name': 'Healthcare Equipment and Supplies'}
Employees
2,003
CEO
Michael R. Minogue, MBA
Website
www.abiomed.comHeadquarters
Danvers, MA 01923, US
ABMD Financials
Key Financial Metrics (TTM)
Gross Margin
82%
Operating Margin
36%
Net Income Margin
13%
Return on Equity
10%
Return on Capital
24%
Return on Assets
8%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$843.60M
Operating Income
$372.69M
EBITDA
$500.46M
Operating Cash Flow
$285.39M
Capital Expenditure
$35.76M
Free Cash Flow
$249.63M
Cash & ST Invst.
$758.61M
Total Debt
$0.00
Abiomed Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$265.92M
+7.2%
Gross Profit
$217.04M
+6.3%
Gross Margin
81.62%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
2,003
N/A
Net Income
$106.13M
+86.4%
EBITDA
$226.14M
+240.4%
Quarterly Fundamentals
Net Cash
$820.37M
+26.1%
Accounts Receivable
$94.47M
+5.5%
Inventory
$102.24M
+18.9%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
8.16%
N/A
Return on Invested Capital
24.28%
N/A
Free Cash Flow
$7.81M
-85.4%
Operating Cash Flow
$13.42M
-77.8%